BioXcel Therapeutics Inc. (BTAI)
NASDAQ: BTAI
· Real-Time Price · USD
1.76
-0.09 (-4.86%)
At close: May 01, 2025, 3:59 PM
1.77
0.57%
After-hours: May 01, 2025, 07:01 PM EDT
BioXcel Therapeutics Revenue
BioXcel Therapeutics reported an annual revenue of $2.27M, reflecting a 64.2% growth. For the quarter ending December 31, 2024, BioXcel Therapeutics generated $366K in revenue.
Revenue (ttm)
$2.27M
Revenue Growth
64.2%
Price / Sales Ratio
6.69
Revenue / Employee
$61.24K
Employees
37
Market Cap
9.66M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 2.27M | +64.20% |
| Dec 31, 2023 | 1.38M | +268.00% |
| Dec 31, 2022 | 375K | +Infinity% |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |